• head_banner_01

OEM/ODM Manufacturer Cas 253870-02-9 With Purity 99% - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our products are broadly identified and trustworthy by people and may meet continually modifying financial and social requires of Sodium Acetate, Testosterone, Piperidine Derivative, In case you are intrigued in almost any of our merchandise, remember to will not hesitate to make contact with us and take the initial step to create up a prosperous enterprise romance.
OEM/ODM Manufacturer Cas 253870-02-9 With Purity 99% - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name  Semaglutide
CAS number  910463-68-2
Molecular formula  C187H291N45O59
Molecular weight  4113.57754
EINECS Number  203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic, 

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.


Product detail pictures:

OEM/ODM Manufacturer Cas 253870-02-9 With Purity 99% - Semaglutide for Type 2 Diabetes – Gentolex detail pictures

OEM/ODM Manufacturer Cas 253870-02-9 With Purity 99% - Semaglutide for Type 2 Diabetes – Gentolex detail pictures


Related Product Guide:

We are also focusing on improving the stuff management and QC system so that we could keep great advantage in the fiercely-competitive business for OEM/ODM Manufacturer Cas 253870-02-9 With Purity 99% - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Canberra, Finland, Sao Paulo, Regarding quality as survival, prestige as guarantee, innovation as motive force, development along with advanced technology, our group hopes to make progress together with you and make untiring efforts for the bright future of this industry.
  • Although we are a small company, we are also respected. Reliable quality, sincere service and good credit, we are honored to be able to work with you!
    5 Stars By Jessie from Amsterdam - 2017.08.16 13:39
    Although we are a small company, we are also respected. Reliable quality, sincere service and good credit, we are honored to be able to work with you!
    5 Stars By Caroline from Zimbabwe - 2017.05.02 18:28
    Write your message here and send it to us